Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 12 Sponsors

Apr 13, 2026 · Senate

Favorable Report by Finance

Apr 13, 2026 · Senate

Favorable

Apr 13, 2026 · Senate

Motion Special Order until Next Session (Senator Love) Adopted

Mar 5, 2026 · Senate

Referred Finance

Mar 4, 2026 · House

Third Reading Passed

Mar 3, 2026 · House

Favorable with Amendments Report by Health

Mar 3, 2026 · House

Favorable with Amendments {

Mar 3, 2026 · House

Second Reading Passed with Amendments

Feb 10, 2026 · House

Hearing canceled

Feb 10, 2026 · House

Hearing 2/10 at 2:30 p.m.

Jan 22, 2026 · House

First Reading Health

Jan 22, 2026 · House

Hearing 2/10 at 2:00 p.m.

PASSAGE PROBABILITY

48.8% Uncertain

Why this number

Stage base Passed First Chamber — base rate 66%, measured from MD's completed sessions
Momentum +5 74/100 from the pace of recorded action
Time since last action -22 181 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.